Roche Holding AG (XSWX:RO) FFO per Share


XSWX:RO Roche Holding AG XSWX:RO
78 GF Score
Price CHF339.20
GF Value CHF269.28
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Roche Holding AG FFO per Share?

FFO per Share only applies to REITs.

XSWX:RO
78GF Score
Roche Holding AG XSWX:RO
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Roche Holding AG (XSWX:RO) Overvalued in 2026?

Based on GuruFocus' analysis, Roche Holding AG stock appears to be overvalued. The current stock price of CHF339.20 is trading 26% above its estimated GF Value™ of CHF269.28. GuruFocus considers Roche Holding AG to be Modestly Overvalued.

Key valuation signals for XSWX:RO:

  • FFO per Share:
  • GF Value™: CHF269.28 vs. price of CHF339.20 (26% above fair value)
  • GF Score™: 78/100 with 7 warning signs

No single metric tells the full story. See the XSWX:RO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Roche Holding AG Business Description

Address Grenzacherstrasse 124, Basel, CHE, 4070
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 40% of pharmaceutical sales, and centralized and point-of-care diagnostics for two-thirds of diagnostic-related sales.
78GF Score

Get the complete analysis for XSWX:RO

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF339.20
Price
CHF269.28
GF Value